Xtl Biopharmaceuticals Inc is categorized under Commercial Medical Research in New Ipswich, NH and active since 1999.
Xtl Biopharmaceuticals Inc was established in 1999, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Martin Becker at the company’s single location by writing to 280 Page Hill Road, New Ipswich, New Hampshire NH 03071 or by phoning (603) 878-9857. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Xtl Biopharmaceuticals Inc |
| Contact Person: | Martin Becker |
| Address: | 280 Page Hill Road, New Ipswich, New Hampshire 03071 |
| Phone Number: | (603) 878-9857 |
| Website Address: | xtlbio.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Xtl Biopharmaceuticals Inc was started in 1999 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Martin Becker for inquiries that concern Xtl Biopharmaceuticals Inc by calling the company number (603) 878-9857, as your correspondence is most welcome. Additionally, the physical location of the single location of Xtl Biopharmaceuticals Inc can be found at the coordinates 42.718741,-71.884395 as well as the street address 280 Page Hill Road in New Ipswich, New Hampshire 03071.
For its online presence, you may visit Xtl Biopharmaceuticals Inc’s website at xtlbio.com and engage with its social media outlets through on Twitter and on Facebook.